Skip to main content
Equibles

Preetam Shah, Ph.D., M.B.A.

CFO

Elicio Therapeutics, Inc. (ELTX)

Chief Accounting Officer

Elicio Therapeutics, Inc. (ELTX)
Elicio Therapeutics, Inc. (ELTX)

Equibles does not estimate personal net worth.

Get an email with a short summary when Elicio Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ELTX alerts

About Preetam Shah, Ph.D., M.B.A.

Preetam Shah, Ph.D., M.B.A. is recorded as CFO and Chief Accounting Officer at Elicio Therapeutics, Inc. (ELTX) since April 1, 2025. Elicio Therapeutics, Inc. reported in an 8-K filed March 24, 2025 that Preetam Shah, Ph.D., M.B.A. was appointed Principal Accounting Officer, effective April 1, 2025. Elicio Therapeutics, Inc. reported in an 8-K filed March 24, 2025 that Preetam Shah, Ph.D., M.B.A. was appointed Principal Financial Officer, effective April 1, 2025. Elicio Therapeutics, Inc. reported in an 8-K filed March 24, 2025 that Preetam Shah, Ph.D., M.B.A. was appointed Chief Strategy and Financial Officer, effective March 24, 2025. Elicio Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Elicio Therapeutics, Inc. includes Robert Connelly (CEO, Chief Accounting Officer and Board Member), Julian Adams (Chairman), Julian Adams, Ph.D. (Chairman and Board Member) and 7 others.

“Effective April 1, 2025, Dr. Shah will also serve as the Company's Principal Financial Officer and Principal Accounting Officer.”
Elicio Therapeutics, Inc. Form 8-K, filed March 24, 2025 · Read the filing
“Effective April 1, 2025, Dr. Shah will also serve as the Company's Principal Financial Officer and Principal Accounting Officer.”
Elicio Therapeutics, Inc. Form 8-K, filed March 24, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Elicio Therapeutics, Inc.

Recent activity